1Festa P, Ait-Ali L,Cerillo AG,et al.Magnetic resonance imaging is the diagnostic tool of choice in the preoperative evaluation of patients with partial anomalous pulmonary venous retum[J].Int J Cardiovasc Imaging,2006,22(5):685-693.
2Beerbaum P, Korperich H,Barth P, et al.Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry[J]. Circulation,2001,103 (20):2476-2482.
3Debl K,Djavidani B,Buchner S,et al.Quantification of left-to-right shunting in adult congenital heart disease: phase-contrast cine MR/ compared with invasive oximetry[J]. Br J Radiol,2009,82(977):38 6-391.
5Weber C,Dill T, Mommert I,et al.The role of MRI for the evaluation of atrial septal defects before and alter percutaneous occlusion with the amplatzer septal occluder(R)[J].Rofo,2002,174( 11): 1387-1394.
6Mansencal N,Martin F Farcot JC,et al.Echocardiographic automated cardiac output measurement of pulmonary output and quantification of intracardiac shunt[J]. Int J Cardiol,2005,104(1):25-31.
9Hata T, Mano S,Kusuki M,et al. Difference in autonomic nervous control between ventricular septal defect and atrial septal defect based on heart rate variability[J].Pacing Clin Electrophysiol,2007, 30(Suppl 1):S212-S214.
5Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int, 2003, 45(3) :249 - 254.
6Mir T, Stephani S, Eiselt M, et al. Plasma concentration of N-terminal pro-brain natriurtic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics,2002, 110(6):e76- 87.
7Kawai K, Hata K, Takaoka H, et al. Plasma brain natriuretic peptide as a noval therapetic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy: a potential of hormone-guided treatment. Am Heart J, 2001, 141(6) :925 - 932.
8Hirata Y, Matsumoto A, Aoyagi T, et al. Measurement of plasma brain natriuretic peptide level as a gudie for cardiac overload. Cardiovasc Res, 2001, 51:585 - 591.
9Kirkwood F, Vandana S, Mihai G, et al. B-Type natriuretic peptide: from bench to bedside. Am Heart J,2003, 145(2) :S34- 46.
10Kinnunen P, Vuolteenaho O, Ruskoaho H, et al. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium:effect of stretching. Endocrinology, 1993, 132(5) :1961- 1970.
1Sayar N,L ti tfullah Orhan A,Cakmak N,et al. Correlation of themyocardial performance index with plasma B-type natriureticpeptide levels in patients with mitral regurgitation [J]. Int JCardiovasc Imaging, 2008,24( 2 ) : 151-157.
2Bramlet M, Moore R,Murphy D,et al. Increase of B-type natriureticpeptide from baseline increase he risk of death or retransplant inpediatric cardiac transplant patients patients,midterm results [J].Congenit Heart Dis, 2010,5 (3 ) : 297-302.
